This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of AbbVie Inc. slipped 5.6% to $177.44 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.1% to 5,892.58 and the Dow Jones Industrial Average falling 0.2% to 42,051.06.
This was the stock's second consecutive day of losses.
AbbVie Inc. closed 18.9% short of its 52-week high of $218.66, which the company achieved on March 10th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson fell 1.4% to $146.36, Pfizer Inc. fell 3.7% to $22.02, and Amgen Inc. fell 3.02% to $262.28.
Trading volume totaled 12.2 million, compared to the 50-day average of 8.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 14, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。